Schaeffers Research
21 Sept 2026, 18:44 UTC · 2h ago
Verdict
Headline takes no side. We score BCRX +0.80 across four claims — strongly bullish.
+0.80strongly bullish
More positive than 84% of ticker scores this week
What the story claims
4 claims · scored −1 bearish … +1 bullish · 0 new · 4 priced in
Short interest in BioCryst Pharmaceuticals (BCRX) represents 14.4% of the available float.
Priced inanalysis of existing trading data
So whatThe eight days of pent-up buying power could trigger a rapid price spike if a catalyst forces a short squeeze.
More positive than 76% of claims this week
BCRX is trading within 3% of its 12-month moving average after closing above the trendline for five consecutive months.
Continue reading
5 related stories
Scored by the NIS engine · methodology.
Priced inanalysis of historical price action
So whatHistorical patterns suggest an 83% probability of positive returns over a three-month horizon following this setup.
More positive than 62% of claims this week
The stock's 14-day Relative Strength Index (RSI) is 32, placing it near oversold territory.
Priced inanalysis of existing technical indicators
So whatAn RSI dip toward 30 often precedes short-term mean reversion, potentially boosting the current 13% YTD gain.
More positive than 50% of claims this week
The Schaeffer's Volatility Index (SVI) for BCRX is 49%, ranking in the 11th percentile of its annual range.
Priced inanalysis of current options pricing
More positive than 41% of claims this week
Which stocks this story touches
More positive than 84% of ticker scores this week
The stock is showing bullish technical signals, reclaiming key moving averages, and showing positive historical return patterns.
Free · No account
Get a free daily PDF briefing — the last 24 hours of news, with summaries and the market-impact score for each story, delivered an hour before the open.
We’ll watch
Pre-filled from this story — remove any you don’t want. Add more tickers & tags or fine-tune your watchlist anytime — every email has an edit link, no account needed.
Free forever · one email a day, max · unsubscribe in one click.How it works
CNBC
5d ago
+0.9%
Price agrees with the score
$8.76 vs $8.68 close before publication (Sep 18) · not market-adjusted
BCRX chart →
